Camillo, CA (PRWEB) October 12, 2009
The GaitAid device, from MediGait LTD, Israel is giving Multiple Sclerosis patients across the country a sometimes first in years relief from the relentless progressive symptoms of the disease. Multiple Sclerosis is a neurological condition which strikes at the myelin sheaths surrounding nerves. The effects are debilitating, patients deal with constant, painful muscle contractions. Every simple action becomes exhaustingly difficult. Walking and balance problems puts patients in additional risk of life threating injuries as a result of falls.
Neurologists have no pharmaceutical agent to offer MS patients to help them with these walking problems.
The GaitAid device is a non-invasive, risk-free aid which brings about a lasting improvement. The portable GaitAid unit clips to the patient's pants. A computer processor inside the device measures walking movement. The processor feedbacks the walking movement by providing visual and auditory cues through special glasses and earphones. To train with the GaitAid, one takes a walk for 5-30 minutes while wearing the device. The feedback mechanism provides rewarding stimuli to good movement making the training enjoyable. Patients often report high motivation during their training.
Often the improvement is immediate and builds up during the first two to four weeks of daily practice. No special training is needed to use the device at home.
Karen Neely from Camillo, CA has been using the GaitAid for the past few weeks. She says, "It felt good to be able to walk more effortlessly and freely without feeling so much fatigue. Since I started using Since I started using the Medigait I could walk more, stand up straighter and walk more and not become nearly as tired when I practiced walking without it. Since I started using the Medigait I could walk more, stand up straighter and walk more and not become nearly as tired when I practiced walking without it. I could walk more, stand up straighter and walk more and not become nearly as tired when I practiced walking without it. It's an experience that feels good."
Clinical studies appearing in medical journals, Neurology, Neural Processing Letters, and Journal of Neurological Sciences showed that %66-%85 of patients improved their walking after training with the GaitAid. Links to this information can be found at http://www.MediGait.com/studies.html
Prof. Ariel Miller, MD, head of the Multiple Sclerosis center, Carmel Medical Hospital in Israel says, "The results clearly indicate that the device helps patients with MS control their gait. The degree of improvement is proportional to the degree of impairment. The results support the potential role of the device as a rehabilitation modality in MS, and substantiate their specific implementation in efforts to alleviate, improve, and restore mobility in patients with gait disturbances due to neurological disorders in general."